Abbey Jenkins

Abbey Jenkins

Director/Board Member at AQUESTIVE THERAPEUTICS, INC.

Net worth: 70 205 $ as of 31/07/2026

50 year
Health Technology
Consumer Services
Technology Services

Profile

Abigail L.
Jenkins
is currently Director at Interstitial Cystitis Association of America, Inc. and Independent Director at Aquestive Therapeutics, Inc. since 2024.
Former roles include President, Chief Executive Officer & Director at Gamida Cell, Inc. and Gamida Cell Ltd. from 2022 to 2024; Director at XORTX Therapeutics, Inc. from 2024 to 2025; Chief Commercial Officer & Head-US Business at Aquinox Pharmaceuticals, Inc.; Head-Commercial & Business Development at Relypsa, Inc. from 2014 to 2016; Senior VP & Business Unit Head-Vaccines at Emergent BioSolutions, Inc. from 2018 to 2021; Vice President-Business Development at Allergan UC from 2011 to 2013; Chief Commercial & Business Officer at Lyndra Therapeutics, Inc. from 2021 to 2022; and Senior Director-Marketing at MedImmune LLC in 2011.
Education includes undergraduate studies at Indiana University and graduate studies at The Johns Hopkins University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
10/06/2026 19,000 ( 0.02% ) 70 205 $ 31/07/2026
19/03/2026 0 ( -.--% ) - $ 31/07/2026

Abbey Jenkins active positions

CompaniesPositionStart
AQUESTIVE THERAPEUTICS, INC. Director/Board Member 01/04/2024
Director/Board Member -

Former positions of Abbey Jenkins

CompaniesPositionEnd
XORTX THERAPEUTICS INC. Director/Board Member 31/12/2025
GAMIDA CELL LTD. Chief Executive Officer 24/05/2024
Chief Executive Officer 24/05/2024
Corporate Officer/Principal 01/08/2022
EMERGENT BIOSOLUTIONS INC. Corporate Officer/Principal 01/03/2021
See the detail of Abbey Jenkins's experience

Training of Abbey Jenkins

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology